Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.

Author: BoboWilliam V

Paper Details 
Original Abstract of the Article :
This article reviews the pharmacological profile and published efficacy and tolerability/safety data of iloperidone, asenapine and lurasidone, the most recent atypical antipsychotics to be approved in the USA for the treatment of schizophrenia. All three agents are similar in terms of overall effica...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1586/ecp.12.70

データ提供:米国国立医学図書館(NLM)

Schizophrenia: Exploring the Latest Pharmacotherapies

Schizophrenia, a complex and challenging mental health condition, requires careful and personalized treatment. This research reviews the pharmacological profiles of three recently approved atypical antipsychotics: iloperidone, asenapine, and lurasidone. The authors meticulously analyze the efficacy and safety data for each drug, seeking to understand their potential benefits and risks for patients with schizophrenia. Their findings provide valuable insights for clinicians seeking to select the most appropriate treatment for their patients.

Atypical Antipsychotics: Navigating the Treatment Landscape

This research offers a comprehensive review of the efficacy and safety profiles of three recently approved atypical antipsychotics: iloperidone, asenapine, and lurasidone. The authors highlight the similarities and differences between these drugs, providing valuable information for clinicians seeking to select the most appropriate treatment option for their patients. Their findings emphasize the importance of considering the individual needs and characteristics of each patient to ensure optimal treatment outcomes.

Understanding the Options: Choosing the Right Path

Imagine a desert oasis, offering a variety of paths leading to different destinations. This research provides a similar map for navigating the treatment options for schizophrenia. By understanding the efficacy and safety profiles of various atypical antipsychotics, clinicians can select the most appropriate treatment for their patients, ensuring a successful journey towards recovery.

Dr.Camel's Conclusion

This research offers valuable insights into the efficacy and safety profiles of three recently approved atypical antipsychotics: iloperidone, asenapine, and lurasidone. The authors provide a comprehensive review of these drugs, highlighting the similarities and differences between them. Their findings contribute to a more informed approach to the treatment of schizophrenia.
Date :
  1. Date Completed 2013-05-14
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

23272794

DOI: Digital Object Identifier

10.1586/ecp.12.70

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.